![Kan Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kan Chen
Direktor/Vorstandsmitglied bei
INSILICO MEDICINE CAYMAN TOPCO
Profil
Kan Chen is currently Non-Executive Director at Chengdu Zenitar Biomedical Technology Co., Ltd. since 2025.
Dr. Chen is Director at CANbridge Life Sciences Ltd., Suzhou Connect Biopharma Co. Ltd., InSilico Medicine Hong Kong Ltd., and InSilico Medicine, Inc. Dr. Chen is Non-Executive Director at InSilico Medicine Cayman TopCo since 2023.
Dr. Chen is Director at Zion Pharma Ltd. and Kira Pharmaceuticals LLC since 2020.
Dr. Chen is Partner at Qiming Venture Partners Ltd. since 2022.
Former roles include Independent Director at Connect Biopharma Holdings Ltd. from 2020 to 2025; Director at Jiangsu Yahong Meditech Co., Ltd. from 2020 to 2021 and from 2020 to 2023; Non-Executive Director at CANbridge Pharmaceuticals Inc. from 2020 to 2024; Director at Abbisko Therapeutics Co., Ltd. from 2020 to 2021; Director at Abbisko Cayman Ltd. from 2020 to 2021; Non-Executive Director at Antengene Corp.
Ltd. from 2021 to 2024; and Non-Executive Director at Antengene Corporation Co., Ltd. Education includes a doctorate from Case Western Reserve University conferred in 2009 and an undergraduate degree from Fudan University conferred in 2004.
Aktive Positionen von Kan Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| INSILICO MEDICINE CAYMAN TOPCO | Direktor/Vorstandsmitglied | 01.08.2021 |
Suzhou Connect Biopharma Co. Ltd.
 Suzhou Connect Biopharma Co. Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops innovative therapies that treat inflammatory diseases | Direktor/Vorstandsmitglied | - |
Chengdu Zeling Biomedical Technology Co. Ltd.
 Chengdu Zeling Biomedical Technology Co. Ltd. BiotechnologyHealth Technology Engages in the research and development of pharmaceutical products | Direktor/Vorstandsmitglied | 01.01.2025 |
InSilico Medicine, Inc.
 InSilico Medicine, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence multiple global collaborations platform | Direktor/Vorstandsmitglied | - |
InSilico Medicine Hong Kong Ltd.
 InSilico Medicine Hong Kong Ltd. Packaged SoftwareTechnology Services Develops AI software for drug discovery | Direktor/Vorstandsmitglied | - |
Kira Pharmaceuticals LLC
 Kira Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in design of complement therapies to treat immune-mediated diseases | Direktor/Vorstandsmitglied | 01.04.2020 |
Qiming Venture Partners Ltd.
 Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners invests in companies located in China. The firm targets companies operating in the fields of technology, consumer and healthcare sectors. It provides financing for growth and early stage capital requirements. | Private Equity Investor | 01.02.2016 |
CANbridge Life Sciences Ltd.
 CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Produces biopharmaceutical products | Direktor/Vorstandsmitglied | - |
Zion Pharma Ltd.
 Zion Pharma Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that research and develops oncology drugs | Direktor/Vorstandsmitglied | 01.08.2020 |
Ehemalige bekannte Positionen von Kan Chen
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Kan Chen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
18
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Qiming Venture Partners Ltd.
Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners invests in companies located in China. The firm targets companies operating in the fields of technology, consumer and healthcare sectors. It provides financing for growth and early stage capital requirements. | Finance |
CANbridge Life Sciences Ltd.
CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Produces biopharmaceutical products | Health Technology |
Abbisko Therapeutics Co., Ltd.
 Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Health Technology |
Suzhou Connect Biopharma Co. Ltd.
Suzhou Connect Biopharma Co. Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops innovative therapies that treat inflammatory diseases | Health Technology |
InSilico Medicine Hong Kong Ltd.
InSilico Medicine Hong Kong Ltd. Packaged SoftwareTechnology Services Develops AI software for drug discovery | Technology Services |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Jiangsu Yahong Meditech Co., Ltd.
 Jiangsu Yahong Meditech Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research, development, production and commercialization of medicines in the fields of urogenital system tumors and major diseases fields | Health Technology |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence multiple global collaborations platform | Technology Services |
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Pharmaceuticals: MajorHealth Technology Develops therapeutic pipeline technology and AI software platform | Health Technology |
Antengene Corp. Ltd.
 Antengene Corp. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes hematologic malignancies therapies | Health Technology |
Connect Biopharma Holdings Ltd.
 Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Zion Pharma Ltd.
Zion Pharma Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that research and develops oncology drugs | Health Technology |
Abbisko Cayman Ltd.
 Abbisko Cayman Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to the discovery and development of small molecule oncology therapies | Health Technology |
CANbridge Pharmaceuticals Inc.
 CANbridge Pharmaceuticals Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Chengdu Zeling Biomedical Technology Co. Ltd.
Chengdu Zeling Biomedical Technology Co. Ltd. BiotechnologyHealth Technology Engages in the research and development of pharmaceutical products | Health Technology |
Kira Pharmaceuticals LLC
Kira Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in design of complement therapies to treat immune-mediated diseases | Health Technology |
